Corus Pharma, Inc.

2025 1st Avenue, Suite 800,
Seattle, Washington 98121
United States,
(206)728-5090
www.coruspharma.com

Corus Pharma is committed to developing and commercializing specialty products for respiratory and infectious diseases that can help provide improved health and superior quality of life.

Corus Pharma was acquired by Gilead Sciences on August 11, 2006.

Join Mergr to view all 119 acquisitions of life science companies in 2006, including 22 acquisitions by private equity firms, and 97 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2006. The largest life science acquisition in 2006 was Guidant - which was acquired by Boston Scientific for $24.6B.

Join Mergr to view this profile - and discover more life science acquisitions of companies like Corus Pharma.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 113K M&A Transactions
  • 122K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.